A STUDY OF THE INCLUSION COMPLEX OF NAPROXEN WITH BETA-CYCLODEXTRIN

被引：84

作者：

ERDEN, N ^{[1
]}

CELEBI, N ^{[1
]}

机构：

[1] GAZI UNIV,FAC PHARM,DEPT PHARMACEUT TECHNOL,06330 ANKARA,TURKEY

来源：

INTERNATIONAL JOURNAL OF PHARMACEUTICS | 1988年 / 48卷 / 1-3期

关键词：

D O I：

10.1016/0378-5173(88)90250-5

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：83 / 89

页数：7

共 30 条

[1]

AGABEYOGLU IT, 1984, 2ND INT S PHARM TECH, P5

[2] THE INFLUENCE OF CYCLODEXTRIN COMPLEXATION ON THE STABILITY OF BETAMETHASONE-17-VALERATE [J].

ANDERSEN, FM ;

BUNDGAARD, H .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1984, 20 (1-2) :155-162

[3] BIOAVAILABILITY OF RECTALLY ADMINISTERED NAPROXEN [J].

CALVO, MV ;

LANAO, JM ;

DOMINGUEZGIL, A .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1987, 38 (1-3) :117-122

[4] INTERACTION OF PHARMACEUTICALS WITH SCHARDINGER DEXTRINS .1. INTERACTION WITH HYDROXYBENZOIC ACIDS AND P-HYDROXYBENZOATES [J].

COHEN, J ;

LACH, JL .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1963, 52 (02) :132-+

[5] THEORETICAL ANALYSIS OF COMPARATIVE STUDIES OF COMPLEX FORMATION - SOLUBILITY SPECTRAL AND KINETIC TECHNIQUES [J].

CONNORS, KA ;

MOLLICA, JA .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1966, 55 (08) :772-&

[6] MECHANISM OF DRUG DISSOLUTION RATE ENHANCEMENT FROM BETA-CYCLODEXTRIN-DRUG SYSTEMS [J].

CORRIGAN, OI ;

STANLEY, CT .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1982, 34 (10) :621-626

[7]

HAMADA Y, 1975, CHEM PHARM BULL, V23, P1205

[8]

Higuchi T., 1965, ADV ANAL CHEM INSTRU, V4, P117

[9]

IKEDA K, 1975, CHEM PHARM BULL, V23, P201

[10]

IWAOKU R, 1982, CHEM PHARM BULL, V30, P1416

← 1 2 3 →